secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viracta Therapeutics, Inc. (—)
CIK:        0001061027
Form:       8-K
Filed at:   2024-07-29T23:59:59+00:00
Accession:  0000950170-24-087020
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Viracta Therapeutics cuts ~23% of workforce; expects $0.7M severance costs
--------------------------------------------------------------------------

- Reduction in force approved July 22, 2024, affecting ~23% of employees.
- Completion expected in August 2024.
- Estimated $0.7M in severance and healthcare benefits expenses.
- Company may incur additional charges not currently anticipated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061027/000095017024087020/0000950170-24-087020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061027/000095017024087020/virx-20240722.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-087020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer